Trial Profile
Health economic assessment of Tygacil [tigecycline] in the treatment of secondary peritonitis in intensive care units
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Oct 2009
Price :
$35
*
At a glance
- Drugs Tigecycline (Primary)
- Indications Peritonitis
- Focus Therapeutic Use
- Sponsors Wyeth
- 29 Sep 2009 Actual patient number (180) added as reported by ClinicalTrials.gov.
- 29 Sep 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 29 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.